Nucleic Acid-Mediated Cleavage of M1 Gene of Influenza A Virus Is Significantly Augmented by Antisense Molecules Targeted to Hybridize Close to the Cleavage Site

@article{Kumar2011NucleicAC,
  title={Nucleic Acid-Mediated Cleavage of M1 Gene of Influenza A Virus Is Significantly Augmented by Antisense Molecules Targeted to Hybridize Close to the Cleavage Site},
  author={Binod Kumar and Madhu Khanna and Pushpendra Kumar and Vikas Sood and Rajesh Vyas and A. C. Banerjea},
  journal={Molecular Biotechnology},
  year={2011},
  volume={51},
  pages={27-36}
}
Influenza A virus genome segment 7 encodes protein M1, which is the matrix protein playing crucial role in the virus life cycle. Any antiviral strategy that aims at reducing, in particular, the expression of this genome segment should, in principle, reduce the infectivity of the virus. We developed a specific antiviral approach at the molecular level and designed several novel 10–23 DNAzymes (Dz) and hammerhead ribozymes (Rz), specifically targeted to cleave at the conserved domains of the… Expand
Sequence-specific cleavage of BM2 gene transcript of influenza B virus by 10-23 catalytic motif containing DNA enzymes significantly inhibits viral RNA translation and replication.
TLDR
The findings suggest that the Dz molecule can be used as selective and effective inhibitor of viral RNA replication, and can be explored further for development of a potent therapeutic agent against influenza B virus infection. Expand
Potent Intracellular Knock-Down of Influenza A Virus M2 Gene Transcript by DNAzymes Considerably Reduces Viral Replication in Host Cells
TLDR
It is suggested that Dz may be used as potential inhibitor of viral RNA replication and can be explored further for development of an effective therapeutic agent against influenza infection. Expand
Cross-Protective Effect of Antisense Oligonucleotide Developed Against the Common 3′ NCR of Influenza A Virus Genome
TLDR
It is demonstrated that a single antisense oligonucleotide is capable of providing protection against more than one strains of the IAV. Expand
RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication
TLDR
The vRNA structure-function relationship was focused on as well as the advantages of using secondary structure information in predicting therapeutic targets and the potential future of this field were presented. Expand
A Conserved Secondary Structural Element in the Coding Region of the Influenza A Virus Nucleoprotein (NP) mRNA Is Important for the Regulation of Viral Proliferation
TLDR
A bioinformatics analysis of segment 5, which encodes nucleoprotein, revealed a conserved structural motif in the (+)RNA that might be a candidate for oligonucleotide-based antiviral therapy. Expand
Knockdown of different influenza A virus subtypes in cell culture by a single antisense oligodeoxyribonucleotide.
TLDR
Very efficient suppression of the reproduction of different subtypes of IAV was probably achieved due to the use of the proposed delivery system for oligonucleotides in the form of the TiO2·PL-DNA nanocomposites, indicating the possibility of creating an efficient drug to affect existing and newly emerging pathogenic IAV strains. Expand
Taming Influenza Virus: Role of Antisense Technology.
TLDR
The present review consolidates the efforts of researchers worldwide in this particular field and discusses the future perspectives this technology holds, to tame this notorious virus. Expand
DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes
TLDR
In comparison with antisense oligonucleotides and small interfering RNAs, Dzs do not usually show off-target effects due to their high specificity and lack of immunogenicity in vivo, so there is a good chance that a deoxyribozyme drug reaching the clinic in the near future. Expand
Efficient inhibition of influenza A viral replication in cells by deoxyribozymes delivered by nanocomposites.
TLDR
The proposed (TiO2•PL)•Dz nanocomposites demonstrated high antiviral activity and are thus potent as nucleic-acid-based drugs. Expand
Unfolding of in planta activity of anti‐rep ribozyme in presence of a RNA silencing suppressor
TLDR
The in planta activity of a hammerhead ribozyme designed to target rep‐mRNA of a phytopathogen Mungbean Yellow Mosaic India virus (MYMIV) as an antiviral agent is demonstrated and RNA‐silencing is induced on introduction of catalytically active as well as inactive ribozymes. Expand
...
1
2
...

References

SHOWING 1-10 OF 20 REFERENCES
Ribozymes that cleave reovirus genome segment S1 also protect cells from pathogenesis caused by reovirus infection
TLDR
Rzs, besides acting as antiviral agents, could be exploited as biological tools to delineate specific functions of target genes to reduce the infectivity of the virus. Expand
Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs.
TLDR
It is shown that varying levels of protection against virus challenge was, observed with novel mutant versions of the chimeric constructs, both targeted against M1 genome segment of influenza A virus. Expand
DNA-enzyme-mediated cleavage of human immunodeficiency virus type 1 Gag RNA is significantly augmented by antisense-DNA molecules targeted to hybridize close to the cleavage site.
TLDR
It was possible to enhance significantly the cleavage activity of poorly cleaving HIV-1 Gag-specific Dzs by using sequence-specific ODNs, and this combination of antisense and catalytic Dz will, in principle, result in more effective gene suppression that could be exploited for therapeutic purposes. Expand
Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA.
TLDR
A ribozyme gene directed at a specific cleavage of mRNA coding for PB1 protein, a component of RNA-dependent RNA-polymerase of influenza A virus, was constructed and the reproduction of A/WSN/33 virus in CV-1 cells preinfected with recombinant adenoviruses was shown to be suppressed. Expand
Sequence-specific cleavage activities of DNA enzymes targeted against HIV-1 Gag and Nef regions.
TLDR
The Gag DNA enzymes could be exploited in combination with other promising antiviral approaches and showed significant variation in their cleavage activities in the presence of varying concentration of Mg(2+) and did not interfere with the replication of a laboratory-adapted HIV-1 isolate under in vitro culture conditions. Expand
Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
TLDR
The importance of the first base pair distal to the XUY within helix I of the hammerhead structure for both in vitro and in vivo ribozyme activities is demonstrated and imply that the effectiveness of the anti-HIV-1 ribozymes against appropriate target sequences is due to their catalytic activities rather than any antisense effect. Expand
siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
TLDR
These proof-of-concept studies demonstrated the utility of RNA-based anti-HIV constructs for gene therapy and described the newly described siRNAs. Expand
Ribozyme mediated destruction of influenza A virus in vitro and in vivo
TLDR
In vitro hammerhead and hairpin ribozymes designed to cleave viral RNA segment 5 of influenza A virus were functional under optimal in vitro conditions, but quantitative measurements indicate that the hammerhead ribozyme is considerably more efficient at this target site than the hairpinribozyme. Expand
Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
TLDR
It is concluded that multitarget-ribozymes retain the specificity of monoribozymes, but they are more efficient per ribozyme RNA copy and they remain active when they are part of a large transcript. Expand
A general purpose RNA-cleaving DNA enzyme.
  • S. Santoro, G. F. Joyce
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1997
TLDR
An in vitro selection procedure was used to develop a DNA enzyme that can be made to cleave almost any targeted RNA substrate under simulated physiological conditions, and its activity is dependent on the presence of Mg2+ ion. Expand
...
1
2
...